EyePoint Pharmaceuticals (EYPT) Shares Outstanding (Weighted Average): 2010-2019
Historic Shares Outstanding (Weighted Average) for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $10.8 million.
- EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) rose 13.98% to $10.8 million in Q4 2019 from the same period last year, while for Sep 2018 it was $7.5 million, marking a year-over-year increase of 89.25%. This contributed to the annual value of $68.3 million for FY2024, which is 93.29% up from last year.
- According to the latest figures from Q4 2019, EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) is $10.8 million, which was up 13.36% from $9.5 million recorded in Q1 2019.
- EyePoint Pharmaceuticals' 5-year Shares Outstanding (Weighted Average) high stood at $10.8 million for Q4 2019, and its period low was $2.9 million during Q1 2015.
- Over the past 3 years, EyePoint Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $5.0 million (recorded in 2017), while the average stood at $6.3 million.
- Data for EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 110.74% (in 2019) over the last 5 years.
- Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $2.9 million in 2015, then rose by 16.18% to $3.4 million in 2016, then soared by 32.42% to $4.5 million in 2017, then soared by 109.59% to $9.5 million in 2018, then climbed by 13.98% to $10.8 million in 2019.
- Its Shares Outstanding (Weighted Average) stands at $10.8 million for Q4 2019, versus $9.5 million for Q1 2019 and $9.5 million for Q4 2018.